The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2023
Filed:
Jan. 11, 2017
Applicant:
Synlogic Operating Company, Inc., Cambridge, MA (US);
Inventors:
Dean Falb, Sherborn, MA (US);
Jonathan W. Kotula, Somerville, MA (US);
Vincent M. Isabella, Cambridge, MA (US);
Paul F. Miller, Salem, CT (US);
Suman Machinani, Cambridge, MA (US);
Saurabh Saha, Wellesley Hills, MA (US);
Adam B. Fisher, Cambridge, MA (US);
Yves Millet, Newton, MA (US);
Ning Li, Winchester, MA (US);
Assignee:
Synlogic Operating Company, Inc., Cambridge, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2020.01); A61K 35/74 (2015.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 14/54 (2006.01); C12N 15/70 (2006.01); C12P 13/22 (2006.01); A61K 38/20 (2006.01); C12N 15/00 (2006.01); C12N 5/00 (2006.01); C07K 14/34 (2006.01); A61K 31/00 (2006.01); C07K 14/335 (2006.01); C07K 14/245 (2006.01); A61K 39/395 (2006.01); C07K 14/535 (2006.01); C07K 14/55 (2006.01); A61K 48/00 (2006.01); A61K 38/19 (2006.01); C12P 21/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/74 (2013.01); A61K 31/00 (2013.01); A61K 38/193 (2013.01); A61K 38/20 (2013.01); A61K 39/3955 (2013.01); A61K 39/39541 (2013.01); A61K 48/00 (2013.01); A61P 35/00 (2018.01); C07K 14/245 (2013.01); C07K 14/335 (2013.01); C07K 14/34 (2013.01); C07K 14/535 (2013.01); C07K 14/54 (2013.01); C07K 14/5434 (2013.01); C07K 14/5443 (2013.01); C07K 14/55 (2013.01); C07K 16/2803 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C12N 5/00 (2013.01); C12N 15/00 (2013.01); C12N 15/70 (2013.01); C12P 13/227 (2013.01); C12P 21/02 (2013.01); A61K 2039/505 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2319/03 (2013.01); C07K 2319/036 (2013.01); C07K 2319/40 (2013.01);
Abstract
Genetically programmed microorganisms, such as bacteria or virus, pharmaceutical compositions thereof, and methods of modulating and treating cancers are disclosed.